PD0166285 dihydrochloride is primarily utilized in research and development within the field of oncology. It is studied for its potential as an inhibitor of specific kinases that play a role in cancer cell proliferation and survival. Researchers investigate its efficacy in targeting signaling pathways that are often dysregulated in various types of cancers, aiming to develop novel therapeutic strategies. Additionally, it is used in preclinical studies to understand its pharmacokinetics, safety profile, and mechanism of action, which are critical for advancing it toward potential clinical trials. Its application is largely confined to laboratory settings, where it aids in the exploration of new cancer treatments.